REBILVEK Trademark

Trademark Overview

On Friday, April 9, 2021, a trademark application was filed for REBILVEK with the United States Patent and Trademark Office. The USPTO has given the REBILVEK trademark a serial number of 90634250. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 7, 2023. This trademark is owned by Krystal Biotech, Inc.. The REBILVEK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in treating skin diseases
rebilvek

General Information

Serial Number90634250
Word MarkREBILVEK
Filing DateFriday, April 9, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in treating skin diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKrystal Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15203
Party NameKrystal Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15203

Trademark Events

Event DateEvent Description
Monday, August 7, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 7, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2023SOU EXTENSION 2 GRANTED
Tuesday, January 3, 2023SOU EXTENSION 2 FILED
Tuesday, January 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 27, 2022SOU EXTENSION 1 GRANTED
Friday, May 27, 2022SOU EXTENSION 1 FILED
Friday, May 27, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 30, 2021ASSIGNED TO EXAMINER
Wednesday, September 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 22, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 13, 2021NEW APPLICATION ENTERED

Related Keywords

rebilvek diseases skin treating preparations pharmaceutical